REGN2810
R2810-ONC-1655
Phase 1 small_molecule completed
Quick answer
REGN2810 for Recurrent Squamous Cell Carcinoma of Head is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Recurrent Squamous Cell Carcinoma of Head
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed